Fragment-Based Drug Discovery Market Size, Share, Growth, and Industry Analysis, By Type (NMR Spectroscopy, DSF Assay, Fluorescence Polarization (FP), Isothermal Titration Calorimetry (ITC), X-ray Crystallography), By Application (Biopharmaceutical Companies, CROs, Academic and Research Institutions), Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Fragment-Based Drug Discovery Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Fragment-Based Drug Discovery Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Fragment-Based Drug Discovery Business Mode and Production Process
2.3.1 Fragment-Based Drug Discovery Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Fragment-Based Drug Discovery Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Fragment-Based Drug Discovery
2.4.2 Raw Material Cost of Fragment-Based Drug Discovery
2.4.3 Labor Cost of Fragment-Based Drug Discovery
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Fragment-Based Drug Discovery Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Fragment-Based Drug Discovery Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Fragment-Based Drug Discovery Price by Manufacturer (2021-2026)
4.4 Fragment-Based Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Fragment-Based Drug Discovery, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Fragment-Based Drug Discovery, Product Offered and Application
4.7 Fragment-Based Drug Discovery Market Competitive Situation and Trends
4.7.1 Fragment-Based Drug Discovery Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Fragment-Based Drug Discovery Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Fragment-Based Drug Discovery Market Historical Development by Geographic Region (2021-2026)
5.1 Global Fragment-Based Drug Discovery Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Fragment-Based Drug Discovery Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Fragment-Based Drug Discovery Market Status by Country (2021-2026)
5.3.1 North America Fragment-Based Drug Discovery Sales Volume by Country (2021-2026)
5.3.2 North America Fragment-Based Drug Discovery Revenue by Country (2021-2026)
5.3.3 United States Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Fragment-Based Drug Discovery Market Status by Country (2021-2026)
5.4.1 Europe Fragment-Based Drug Discovery Sales Volume by Country (2021-2026)
5.4.2 Europe Fragment-Based Drug Discovery Revenue by Country (2021-2026)
5.4.3 Germany Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Fragment-Based Drug Discovery Market Status by Country (2021-2026)
5.5.1 Asia Pacific Fragment-Based Drug Discovery Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Fragment-Based Drug Discovery Revenue by Country (2021-2026)
5.5.3 China Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Fragment-Based Drug Discovery Market Status by Country (2021-2026)
5.6.1 Latin America Fragment-Based Drug Discovery Sales Volume by Country (2021-2026)
5.6.2 Latin America Fragment-Based Drug Discovery Revenue by Country (2021-2026)
5.6.3 Mexico Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Fragment-Based Drug Discovery Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Fragment-Based Drug Discovery Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Fragment-Based Drug Discovery Revenue by Country (2021-2026)
5.7.3 GCC Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Fragment-Based Drug Discovery Sales Volume, Revenue and Growth (2021-2026)

6 Global Fragment-Based Drug Discovery Market Historical Development by Product Type (2021-2026)
6.1 Fragment-Based Drug Discovery Definition by Type
6.2 Global Fragment-Based Drug Discovery Historical Sales Volume by Product Type (2021-2026)
6.3 Global Fragment-Based Drug Discovery Historical Revenue by Product Type (2021-2026)
6.4 Global Fragment-Based Drug Discovery Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Fragment-Based Drug Discovery Historical Sales Volume, Revenue and Growth Rate of NMR Spectroscopy (2021-2026)
6.5.2 Global Fragment-Based Drug Discovery Historical Sales Volume, Revenue and Growth Rate of DSF Assay (2021-2026)
6.5.3 Global Fragment-Based Drug Discovery Historical Sales Volume, Revenue and Growth Rate of Fluorescence Polarization (FP) (2021-2026)
6.5.4 Global Fragment-Based Drug Discovery Historical Sales Volume, Revenue and Growth Rate of Isothermal Titration Calorimetry (ITC) (2021-2026)
6.5.5 Global Fragment-Based Drug Discovery Historical Sales Volume, Revenue and Growth Rate of X-ray Crystallography (2021-2026)

7 Global Fragment-Based Drug Discovery Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Fragment-Based Drug Discovery Historical Sales Volume by End User (2021-2026)
7.3 Global Fragment-Based Drug Discovery Historical Revenue by End User (2021-2026)
7.4 Global Fragment-Based Drug Discovery Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Fragment-Based Drug Discovery Historical Sales Volume, Revenue and Growth Rate of Biopharmaceutical Companies (2021-2026)
7.5.2 Global Fragment-Based Drug Discovery Historical Sales Volume, Revenue and Growth Rate of CROs (2021-2026)
7.5.3 Global Fragment-Based Drug Discovery Historical Sales Volume, Revenue and Growth Rate of Academic and Research Institutions (2021-2026)

8 Leading Companies Profiles
8.1 Emerald BioStructures, Inc
8.1.1 Emerald BioStructures, Inc Corporation Information
8.1.2 Emerald BioStructures, Inc - Fragment-Based Drug Discovery Product Portfolio and Specification
8.1.3 Emerald BioStructures, Inc Performance Analysis (2021-2026)
8.1.4 Emerald BioStructures, Inc Business and Markets Served
8.1.5 Emerald BioStructures, Inc Recent Developments
8.2 Evotec AG
8.2.1 Evotec AG Corporation Information
8.2.2 Evotec AG - Fragment-Based Drug Discovery Product Portfolio and Specification
8.2.3 Evotec AG Performance Analysis (2021-2026)
8.2.4 Evotec AG Business and Markets Served
8.2.5 Evotec AG Recent Developments
8.3 Crown Bioscience, Inc
8.3.1 Crown Bioscience, Inc Corporation Information
8.3.2 Crown Bioscience, Inc - Fragment-Based Drug Discovery Product Portfolio and Specification
8.3.3 Crown Bioscience, Inc Performance Analysis (2021-2026)
8.3.4 Crown Bioscience, Inc Business and Markets Served
8.3.5 Crown Bioscience, Inc Recent Developments
8.4 Charles River Laboratories International, Inc
8.4.1 Charles River Laboratories International, Inc Corporation Information
8.4.2 Charles River Laboratories International, Inc - Fragment-Based Drug Discovery Product Portfolio and Specification
8.4.3 Charles River Laboratories International, Inc Performance Analysis (2021-2026)
8.4.4 Charles River Laboratories International, Inc Business and Markets Served
8.4.5 Charles River Laboratories International, Inc Recent Developments
8.5 Structure Based Design, Inc
8.5.1 Structure Based Design, Inc Corporation Information
8.5.2 Structure Based Design, Inc - Fragment-Based Drug Discovery Product Portfolio and Specification
8.5.3 Structure Based Design, Inc Performance Analysis (2021-2026)
8.5.4 Structure Based Design, Inc Business and Markets Served
8.5.5 Structure Based Design, Inc Recent Developments
8.6 Beactica AB
8.6.1 Beactica AB Corporation Information
8.6.2 Beactica AB - Fragment-Based Drug Discovery Product Portfolio and Specification
8.6.3 Beactica AB Performance Analysis (2021-2026)
8.6.4 Beactica AB Business and Markets Served
8.6.5 Beactica AB Recent Developments
8.7 Astex Pharmaceuticals
8.7.1 Astex Pharmaceuticals Corporation Information
8.7.2 Astex Pharmaceuticals - Fragment-Based Drug Discovery Product Portfolio and Specification
8.7.3 Astex Pharmaceuticals Performance Analysis (2021-2026)
8.7.4 Astex Pharmaceuticals Business and Markets Served
8.7.5 Astex Pharmaceuticals Recent Developments
8.8 Kinetic Discovery Limited
8.8.1 Kinetic Discovery Limited Corporation Information
8.8.2 Kinetic Discovery Limited - Fragment-Based Drug Discovery Product Portfolio and Specification
8.8.3 Kinetic Discovery Limited Performance Analysis (2021-2026)
8.8.4 Kinetic Discovery Limited Business and Markets Served
8.8.5 Kinetic Discovery Limited Recent Developments
8.9 Proteros Fragments GmbH
8.9.1 Proteros Fragments GmbH Corporation Information
8.9.2 Proteros Fragments GmbH - Fragment-Based Drug Discovery Product Portfolio and Specification
8.9.3 Proteros Fragments GmbH Performance Analysis (2021-2026)
8.9.4 Proteros Fragments GmbH Business and Markets Served
8.9.5 Proteros Fragments GmbH Recent Developments
8.10 Sprint Bioscience
8.10.1 Sprint Bioscience Corporation Information
8.10.2 Sprint Bioscience - Fragment-Based Drug Discovery Product Portfolio and Specification
8.10.3 Sprint Bioscience Performance Analysis (2021-2026)
8.10.4 Sprint Bioscience Business and Markets Served
8.10.5 Sprint Bioscience Recent Developments
8.11 Sygnature Discovery
8.11.1 Sygnature Discovery Corporation Information
8.11.2 Sygnature Discovery - Fragment-Based Drug Discovery Product Portfolio and Specification
8.11.3 Sygnature Discovery Performance Analysis (2021-2026)
8.11.4 Sygnature Discovery Business and Markets Served
8.11.5 Sygnature Discovery Recent Developments
8.12 Alveus Pharmaceuticals Pvt. Ltd
8.12.1 Alveus Pharmaceuticals Pvt. Ltd Corporation Information
8.12.2 Alveus Pharmaceuticals Pvt. Ltd - Fragment-Based Drug Discovery Product Portfolio and Specification
8.12.3 Alveus Pharmaceuticals Pvt. Ltd Performance Analysis (2021-2026)
8.12.4 Alveus Pharmaceuticals Pvt. Ltd Business and Markets Served
8.12.5 Alveus Pharmaceuticals Pvt. Ltd Recent Developments

9 Global Fragment-Based Drug Discovery Market Forecast by Product Type and End User (2026-2034)
9.1 Global Fragment-Based Drug Discovery Market Forecast by Product Type (2026-2034)
9.1.1 Global Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of NMR Spectroscopy (2026-2034)
9.1.2 Global Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of DSF Assay (2026-2034)
9.1.3 Global Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of Fluorescence Polarization (FP) (2026-2034)
9.1.4 Global Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of Isothermal Titration Calorimetry (ITC) (2026-2034)
9.1.5 Global Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of X-ray Crystallography (2026-2034)
9.2 Global Fragment-Based Drug Discovery Market Forecast by End User (2026-2034)
9.2.1 Global Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of Biopharmaceutical Companies (2026-2034)
9.2.2 Global Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of CROs (2026-2034)
9.2.3 Global Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth Rate of Academic and Research Institutions (2026-2034)

10 Global Fragment-Based Drug Discovery Market Forecast by Geographic Region (2026-2034)
10.1 Global Fragment-Based Drug Discovery Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Fragment-Based Drug Discovery Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer